Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Acronyms


3. Research Methodology


4. Executive Summary: Global Recombinant Factor C Assay Market


5. Market Overview

5.1. Definition

5.2. Market Indicators

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunities

5.4. Global Recombinant Factor C Assay Market Revenue (US$ Mn) Forecast 2017–2027

5.5. Global Recombinant Factor C Assay Market Outlook


6. Key Insights

6.1. Value Chain Analysis

6.2. Key Industry Events

6.3. Patent Analysis

6.4. Product Features & USPs

6.5. Overview of Pyrogen Testing Products Market

6.5.1. Pyrogen Testing- Service Providers

6.5.2. Pyrogen Testing Products Marketing, by Country/Region

6.6. Overview of Limulus Amoebocyte Lysate (LAL) Tests

6.6.1. Number of Assays Performed

6.6.2. Cost per Assay and Turn Around Time

6.7. Regulatory Scenario, by Country/Region

6.8. Institutes Involved in Research Studies using Horseshoe Crabs


7. Global Recombinant Factor C Assay Market Analysis and Forecast, by Brand

7.1. Introduction

7.2. Global Recombinant Factor C Assay Market Value Share Analysis, by Brand

7.3. Global Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

7.3.1. PyroGene

7.3.1.1. PyroGene Bulk rFC (2,880 tests)

7.3.1.2. PyroGene rFC (192 tests)

7.3.2. EndoNext

7.3.2.1. Endozyme II

7.3.2.2. Endozyme II GO

7.3.2.3. EndoLisa

7.4. Global Recombinant Factor C Assay Market Attractiveness, by Brand


8. Global Recombinant Factor C Assay Market Analysis and Forecast, by End-user

8.1. Introduction

8.2. Global Recombinant Factor C Assay Market Value Share Analysis, by End-user

8.3. Global Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

8.3.1. Pharmaceutical Companies

8.3.2. Biotechnology Companies

8.3.3. Medical Device Companies

8.3.4. Contract Research Organizations (CROs)

8.4. Global Recombinant Factor C Assay Market Attractiveness, by End-user


9. Global Recombinant Factor C Assay Market Analysis and Forecast, by Region

9.1. Regional Outlook

9.2. Introduction

9.3. Global Recombinant Factor C Assay Market Value Forecast, by Region

9.3.1. North America

9.3.2. Europe

9.3.3. Asia Pacific

9.3.4. Latin America

9.3.5. Middle East & Africa

9.4. Global Recombinant Factor C Assay Market Attractiveness, by Region


10. North America Recombinant Factor C Assay Market Analysis and Forecast

10.1. Key Findings

10.2. North America Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

10.2.1. PyroGene

10.2.1.1. PyroGene Bulk rFC (2,880 tests)

10.2.1.2. PyroGene rFC (192 tests)

10.2.2. EndoNext

10.2.2.1. Endozyme II

10.2.2.2. Endozyme II GO

10.2.2.3. EndoLisa

10.3. North America Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

10.3.1. Pharmaceutical Companies

10.3.2. Biotechnology Companies

10.3.3. Medical Device Companies

10.3.4. Contract Research Organizations (CROs)

10.4. North America Recombinant Factor C Assay Market Value Forecast, by Country, 2017–2027

10.4.1. U.S.

10.4.2. Canada

10.5. North America Recombinant Factor C Assay Market Attractiveness Analysis

10.5.1. By Brand

10.5.2. By End-user

10.5.3. By Country


11. Europe Recombinant Factor C Assay Market Analysis and Forecast

11.1. Key Findings

11.2. Europe Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

11.2.1. PyroGene

11.2.1.1. PyroGene Bulk rFC (2,880 tests)

11.2.1.2. PyroGene rFC (192 tests)

11.2.2. EndoNext

11.2.2.1. Endozyme II

11.2.2.2. Endozyme II GO

11.2.2.3. EndoLisa

11.3. Europe Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

11.3.1. Pharmaceutical Companies

11.3.2. Biotechnology Companies

11.3.3. Medical Device Companies

11.3.4. Contract Research Organizations (CROs)

11.4. Europe Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027

11.4.1. U.K.

11.4.2. Germany

11.4.3. France

11.4.4. Italy

11.4.5. Spain

11.4.6. Rest of Europe

11.5. Europe Recombinant Factor C Assay Market Attractiveness Analysis

11.5.1. By Brand

11.5.2. By End-user

11.5.3. By Country/Sub-region


12. Asia Pacific Recombinant Factor C Assay Market Analysis and Forecast

12.1. Key Findings

12.2. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

12.2.1. PyroGene

12.2.1.1. PyroGene Bulk rFC (2,880 tests)

12.2.1.2. PyroGene rFC (192 tests)

12.2.2. EndoNext

12.2.2.1. Endozyme II

12.2.2.2. Endozyme II GO

12.2.2.3. EndoLisa

12.3. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

12.3.1. Pharmaceutical Companies

12.3.2. Biotechnology Companies

12.3.3. Medical Device Companies

12.3.4. Contract Research Organizations (CROs)

12.4. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027

12.4.1. China

12.4.2. India

12.4.3. Japan

12.4.4. Australia & New Zealand

12.4.5. Rest of Asia Pacific

12.5. Asia Pacific Recombinant Factor C Assay Market Attractiveness Analysis

12.5.1. By Brand

12.5.2. By End-user

12.5.3. By Country/Sub-region

13. Latin America Recombinant Factor C Assay Market Analysis and Forecast

13.1. Key Findings

13.2. Latin America Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

13.2.1. PyroGene

13.2.1.1. PyroGene Bulk rFC (2,880 tests)

13.2.1.2. PyroGene rFC (192 tests)

13.2.2. EndoNext

13.2.2.1. Endozyme II

13.2.2.2. Endozyme II GO

13.2.2.3. EndoLisa

13.3. Latin America Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

13.3.1. Pharmaceutical Companies

13.3.2. Biotechnology Companies

13.3.3. Medical Device Companies

13.3.4. Contract Research Organizations (CROs)

13.4. Latin America Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027

13.4.1. Brazil

13.4.2. Mexico

13.4.3. Rest of Latin America

13.5. Latin America Recombinant Factor C Assay Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By End-user

13.5.3. By Country/Sub-region

14. Middle East & Africa Recombinant Factor C Assay Market Analysis and Forecast

14.1. Key Findings

14.2. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

14.2.1. PyroGene

14.2.1.1. PyroGene Bulk rFC (2,880 tests)

14.2.1.2. PyroGene rFC (192 tests)

14.2.2. EndoNext

14.2.2.1. Endozyme II

14.2.2.2. Endozyme II GO

14.2.2.3. EndoLisa

14.3. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

14.3.1. Pharmaceutical Companies

14.3.2. Biotechnology Companies

14.3.3. Medical Device Companies

14.3.4. Contract Research Organizations (CROs)

14.4. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027

14.4.1. GCC Countries

14.4.2. South Africa

14.4.3. Rest of Middle East & Africa

14.5. Middle East & Africa Recombinant Factor C Assay Market Attractiveness Analysis

14.5.1. By Product

14.5.2. By End-user

14.5.3. By Country/Sub-region


15. Competition Landscape

15.1. Company Share Analysis

15.2. Company Profiles

15.2.1. Lonza Group

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Financial Overview

15.2.1.3. Product Portfolio

15.2.1.4. Strategic Overview

15.2.1.5. SWOT Analysis

15.2.2. Hyglos GmbH – a bioM?rieux Company

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Financial Overview

15.2.2.3. Product Portfolio

15.2.2.4. Strategic Overview

15.2.2.5. SWOT Analysis



List of Figures



Figure 01: Global Recombinant Factor C Assay Market Snapshot

Figure 02: Global Recombinant Factor C Assay Market Value (US$ Thousand), by Region, 2018 and 2027

Figure 03: Global Recombinant Factor C Assay Market Value (US$ Thousand) and Y-o-Y (%) Forecast, 2017–2027

Figure 04: Global Recombinant Factor C Assay Market Value Share, by Brand, 2019

Figure 05: Global Recombinant Factor C Assay Market Value Share, by End-user, 2019

Figure 06: Global Recombinant Factor C Assay Market Value Share, by Region, 2019

Figure 07: Value Chain Analysis – Recombinant Factor C Assay Market

Figure 08: Key Industry Events – Recombinant Factor C Assays Market

Figure 09: Regulatory Scenario – North America

Figure 10: Regulatory Scenario – Europe

Figure 11: Regulatory Scenario – Asia Pacific

Figure 12: Global Recombinant Factor C Assay Market Value Share Analysis, by Brand, 2018 and 2027

Figure 13: Global Recombinant Factor C Assay Market Attractiveness Analysis, by Brand, 2019–2027

Figure 14: Global Recombinant Factor C Assay Market Revenue (US$ Thousand) and Y-o-Y Growth (%), by PyroGene, 2017–2027

Figure 15: Global Recombinant Factor C Assay Market Revenue (US$ Thousand) and Y-o-Y Growth (%), by EndoNext, 2017–2027

Figure 16: Key Trends – By Brand

Figure 17: Global Recombinant Factor C Assay Market Value Share Analysis, by End-user, 2018 and 2027

Figure 18: Global Recombinant Factor C Assay Market Attractiveness Analysis, by End-user, 2019–2027

Figure 19: Global Recombinant Factor C Assay Market Revenue (US$ Thousand) and Y-o-Y Growth (%), by Pharmaceutical Companies, 2017–2027

Figure 20: Global Recombinant Factor C Assay Market Revenue (US$ Thousand) and Y-o-Y Growth (%), by Biotechnology Companies, 2017–2027

Figure 21: Global Recombinant Factor C Assay Market Revenue (US$ Thousand) and Y-o-Y Growth (%), by Medical Device Companies, 2017–2027

Figure 22: Global Recombinant Factor C Assay Market Revenue (US$ Thousand) and Y-o-Y Growth (%), by Contract Research Organizations (CROs), 2017–2027

Figure 23: Key Trends – By End-user

Figure 24: Recombinant Factor C Assay Market – Regional Outlook

Figure 25: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, 2017–2027

Figure 26: Global Recombinant Factor C Assay Market Value Share Analysis, by Region, 2018 and 2027

Figure 27: Global Recombinant Factor C Assay Market Attractiveness Analysis, by Region, 2019–2027

Figure 28: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 29: North America Recombinant Factor C Assay Market Value Share Analysis, by Country, 2018 and 2027

Figure 30: North America Recombinant Factor C Assay Market Attractiveness Analysis, by Country, 2019–2027

Figure 31: North America Recombinant Factor C Assay Market Value Share Analysis, by Brand, 2018 and 2027

Figure 32: North America Recombinant Factor C Assay Market Attractiveness Analysis, by Brand, 2019–2027

Figure 33: North America Recombinant Factor C Assay Market Value Share Analysis, by End-user, 2018 and 2027

Figure 34: North America Recombinant Factor C Assay Market Attractiveness Analysis, by End-user, 2019–2027

Figure 35: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 36: Europe Recombinant Factor C Assay Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 37: Europe Recombinant Factor C Assay Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 38: Europe Recombinant Factor C Assay Market Value Share Analysis, by Brand, 2018 and 2027

Figure 39: Europe Recombinant Factor C Assay Market Attractiveness Analysis, by Brand, 2019–2027

Figure 40: Europe Recombinant Factor C Assay Market Value Share Analysis, by End-user, 2018 and 2027

Figure 41: Europe Recombinant Factor C Assay Market Attractiveness Analysis, by End-user, 2019–2027

Figure 42: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 43: Asia Pacific Recombinant Factor C Assay Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 44: Asia Pacific Recombinant Factor C Assay Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 45: Asia Pacific Recombinant Factor C Assay Market Value Share Analysis, by Brand, 2018 and 2027

Figure 46: Asia Pacific Recombinant Factor C Assay Market Attractiveness Analysis, by Brand, 2019–2027

Figure 47: Asia Pacific Recombinant Factor C Assay Market Value Share Analysis, by End-user, 2018 and 2027

Figure 48: Asia Pacific Recombinant Factor C Assay Market Attractiveness Analysis, by End-user, 2019–2027

Figure 49: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 50: Latin America Recombinant Factor C Assay Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 51: Latin America Recombinant Factor C Assay Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 52: Latin America Recombinant Factor C Assay Market Value Share Analysis, by Brand, 2018 and 2027

Figure 53: Latin America Recombinant Factor C Assay Market Attractiveness Analysis, by Brand, 2019–2027

Figure 54: Latin America Recombinant Factor C Assay Market Value Share Analysis, by End-user, 2018 and 2027

Figure 55: Latin America Recombinant Factor C Assay Market Attractiveness Analysis, by End-user, 2019–2027

Figure 56: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 57: Middle East & Africa Recombinant Factor C Assay Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 58: Middle East & Africa Recombinant Factor C Assay Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 59: Middle East & Africa Recombinant Factor C Assay Market Value Share Analysis, by Brand, 2018 and 2027

Figure 60: Middle East & Africa Recombinant Factor C Assay Market Attractiveness Analysis, by Brand, 2019–2027

Figure 61: Middle East & Africa Recombinant Factor C Assay Market Value Share Analysis, by End-user, 2018 and 2027

Figure 62: Middle East & Africa Recombinant Factor C Assay Market Attractiveness Analysis, by End-user, 2019–2027

Figure 63: Global Recombinant Factor C Assay Market Analysis, by Top Company Ranking, 2018


List of Tables



Table 01: Patent Information – Pyrogene (Lonza)

Table 02: Patent Information – EndoLisa

Table 03: Patent Information – EndoZyme II GO

Table 04: Patent Information – Recombinant Factor C Assay Market

Table 05: Product Features & USPs – Recombinant Factor C Assays

Table 06: Pyrogen Testing- Service Providers

Table 07: Pyrogen Testing- Service Providers

Table 08: Pyrogen Testing Products Marketing

Table 09: Cost per Assay and Turn Around Time (LAL)

Table 10: Institutes Involved in Research Studies using Horseshoe Crabs

Table 11: Institutes Focused on Conversing Horseshoe Crabs

Table 12: Pyrogen Testing Market Offerings, By Company

Table 13: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 14: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 15: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 16: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 17: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Region, 2017–2027

Table 18: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country, 2017–2027

Table 19: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 20: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 21: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 22: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 23: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027

Table 24: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 25: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 26: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 27: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 28: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027

Table 29: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 30: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 31: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 32: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 33: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027

Table 34: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 35: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 36: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 37: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 38: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027

Table 39: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 40: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 41: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 42: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027